Affective lability in offspring of parents with major depressive disorder, bipolar disorder and schizophrenia.


Journal

European child & adolescent psychiatry
ISSN: 1435-165X
Titre abrégé: Eur Child Adolesc Psychiatry
Pays: Germany
ID NLM: 9212296

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 17 08 2018
accepted: 16 05 2019
pubmed: 7 6 2019
medline: 1 7 2020
entrez: 8 6 2019
Statut: ppublish

Résumé

Affective lability, defined as the propensity to experience excessive and unpredictable changes in mood, has been proposed as a potential transdiagnostic predictor of major mood and psychotic disorders. A parental diagnosis of bipolar disorder has been associated with increased affective lability in offspring. However, the association between affective lability and family history of other mood and psychotic disorders has not been examined. We measured affective lability using the self- and parent-reported Children's Affective Lability Scale in a cohort of 320 youth aged 6-17 years, including 137 offspring of a parent with major depressive disorder, 68 offspring of a parent with bipolar disorder, 24 offspring of a parent with schizophrenia, and 91 offspring of control parents. We tested differences in affective lability between groups using mixed-effects linear regression. Offspring of a parent with major depressive disorder (β = 0.46, 95% CI 0.17-0.76, p = 0.002) or bipolar disorder (β = 0.47, 95% CI 0.12-0.81, p = 0.008) had significantly higher affective lability scores than control offspring. Affective lability did not differ significantly between offspring of a parent with schizophrenia and offspring of control parents. Our results suggest that elevated affective lability during childhood is a marker of familial risk for mood disorders.

Identifiants

pubmed: 31172297
doi: 10.1007/s00787-019-01355-z
pii: 10.1007/s00787-019-01355-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

445-451

Subventions

Organisme : Canada Research Chairs
ID : 231397
Organisme : CIHR
ID : 124976
Pays : Canada
Organisme : CIHR
ID : 142738
Pays : Canada
Organisme : CIHR
ID : 148394
Pays : Canada
Organisme : Brain and Behavior Research Foundation
ID : 24684
Organisme : Nova Scotia Health Research Foundation
ID : 275319
Organisme : Nova Scotia Health Research Foundation
ID : 1716
Organisme : Nova Scotia Health Research Foundation
ID : 353892

Références

Transl Psychiatry. 2018 Oct 2;8(1):205
pubmed: 30279410
Compr Psychiatry. 2012 Apr;53(3):230-7
pubmed: 21632042
Annu Rev Clin Psychol. 2015;11:379-405
pubmed: 25581242
JAMA Psychiatry. 2013 Jan;70(1):22-30
pubmed: 23147713
Nature. 2011 Oct 04;478(7367):15
pubmed: 21979020
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):90-3
pubmed: 27007451
BMC Psychiatry. 2014 Dec 02;14:344
pubmed: 25439055
JAMA Psychiatry. 2017 Feb 1;74(2):153-160
pubmed: 27926743
J Affect Disord. 2005 Mar;85(1-2):181-9
pubmed: 15780688
Br J Psychiatry. 2018 Sep;213(3):555-560
pubmed: 29925436
World Psychiatry. 2017 Jun;16(2):121-129
pubmed: 28498595
J Child Adolesc Psychopharmacol. 2016 Mar;26(2):107-13
pubmed: 26771536
Br J Psychiatry. 2017 Jun;210(6):408-412
pubmed: 28385707
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
Psychiatry Res. 1996 Dec 20;65(3):189-98
pubmed: 9029668
Arch Gen Psychiatry. 2010 Mar;67(3):252-7
pubmed: 20194825
Schizophr Bull. 2014 Jan;40(1):28-38
pubmed: 23960245
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Nat Genet. 2013 Sep;45(9):984-94
pubmed: 23933821
J Child Psychol Psychiatry. 2014;55(2):144-53
pubmed: 24372351
Clin Psychol Sci. 2014 Mar;2(2):119-137
pubmed: 25360393
Bipolar Disord. 2013 May;15(3):253-63
pubmed: 23551755
Schizophr Bull. 2014 Mar;40(2):269-77
pubmed: 24162517
Science. 2018 Feb 9;359(6376):693-697
pubmed: 29439242
J Affect Disord. 2011 Apr;130(1-2):53-9
pubmed: 20951438
Psychiatry Res. 2017 May;251:162-167
pubmed: 28208077
Am J Psychiatry. 2016 Jul 1;173(7):695-704
pubmed: 26892940
PLoS One. 2017 Feb 6;12(2):e0171595
pubmed: 28166306
Psychol Med. 2018 Sep;48(12):1925-1936
pubmed: 29334044
Bipolar Disord. 2015 Dec;17(8):814-20
pubmed: 26576693
Br J Psychiatry. 2015 Oct;207(4):283-5
pubmed: 26429679

Auteurs

Alyson Zwicker (A)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Pathology, Dalhousie University, Halifax, NS, Canada.

Vladislav Drobinin (V)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Medical Neuroscience, Dalhousie University, Halifax, NS, Canada.

Lynn E MacKenzie (LE)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada.

Emily Howes Vallis (E)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Victoria C Patterson (VC)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada.

Jill Cumby (J)

Nova Scotia Health Authority, Halifax, NS, Canada.

Lukas Propper (L)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
IWK Health Centre, Halifax, NS, Canada.

Sabina Abidi (S)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
IWK Health Centre, Halifax, NS, Canada.

Alexa Bagnell (A)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
IWK Health Centre, Halifax, NS, Canada.

Barbara Pavlova (B)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Martin Alda (M)

Nova Scotia Health Authority, Halifax, NS, Canada.
Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Rudolf Uher (R)

Nova Scotia Health Authority, Halifax, NS, Canada. uher@dal.ca.
Department of Pathology, Dalhousie University, Halifax, NS, Canada. uher@dal.ca.
Department of Medical Neuroscience, Dalhousie University, Halifax, NS, Canada. uher@dal.ca.
Department of Psychology and Neuroscience, Dalhousie University, Halifax, NS, Canada. uher@dal.ca.
Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. uher@dal.ca.
IWK Health Centre, Halifax, NS, Canada. uher@dal.ca.
Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. uher@dal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH